Skip to content
Skip to search
Skip to footer
- CORCINCH: Randomized clinical evaluation of the AccuCinch Ventricular Restoration System in patients who present with symptomatic heart failure with reduced ejection fraction. Justin Vader, MD. Ancora Heart.
- DAPA-ACT HF: Evaluating the Effect of in-hospital initiation of dapagliflozin on clinical outcomes in patients who have been stabilized during hospitalization for acute heart failure. Justin Hartupee, MD. AstroZeneca Pharmaceuticals LP.
- DCM Consortium: Identification of the genetic causes of dilated cardiomyopathy and related conditions. Gregory Ewald, MD. Ohio State University.
- Garden-TIMI: Investigating symptoms, function, health-related quality of life and safety with repeated subcutaneous administration of ponsegromab v placebo in adult participants with heart failure. Justin Hartupee, MD. Pfizer Inc. (pending)
- Lilly: A single dose study evaluating different dose levels and subcutaneous infusion durations on safety, pharmacokinetics and pharmacodynamics of LY3461767 in participants with chronic heart failure with reduced ejection fraction. Gregory Ewald, MD. Eli Lilly and Company.
- ManageHF: A multifaceted adaptive mobile application to promote self-management and improve outcomes in heart failure. Gregory Ewald, MD. University of Michigan.
- MUSIC-HF: Phase I/II trial of the safety and efficacy of SRD-001 in subjects with heart failure with reduced ejection fraction. Gregory Ewald, MD. Sardocor Corp.
- MYIA: Usability and utility assessment of passive remote monitoring of multiple novel indicators of heart failure. Gregory Ewald, MD. Healthcare Innovation Lab.
- REBIRTH: Randomized evaluation of bromocriptine in myocardial recovery therapy for peripartum cardiomyopathy. Gregory Ewald, MD. University of Pittsburgh.
- REHAB-pEF Physical Rehabilitation for older patients with acute heart failure with preserved ejection fraction. Justin Vader, MD. National Institute of Aging.
- RESONANCE: Registry of the natural history of recurrent pericarditis in pediatric and adult patients. Amanda Verma, MD. Kiniksa Pharmaceuticals.
- SALUBRIS: A study to assess the safety and tolerability of JK07 in subjects with heart failure with preserved ejection fraction. Nancy Sweitzer, MD. Salubris Biotherapeutics, Inc.
- SHORE: Surveillance Heartcare (allomap and allosure) outcomes registry. Gregory Ewald, MD. CareDx.
- TCBR: Translational cardiovascular biobank and repository. Gregory Ewald, MD. Washington University.
- VICTOR: Phase 3 study evaluating the efficacy and safety of sGC Stimulator vericiguat in adults with chronic heart failure with reduced ejection fraction. Gregory Ewald, MD. Merck Sharp & Dohme LLC